Argolyn Raises First Round

Argolyn Bioscience Inc., a Charleston, S.C.-based drug company focused on psychosis and pain, has raised $15.8 million in first-round funding. Intersouth Partners and Quaker BioVentures co-led the deal, and were joined by Amgen Ventures. www.argolyn.com